Radhika Narla

532 total citations
19 papers, 353 citations indexed

About

Radhika Narla is a scholar working on Orthopedics and Sports Medicine, Surgery and Oncology. According to data from OpenAlex, Radhika Narla has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Orthopedics and Sports Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Radhika Narla's work include Bone health and osteoporosis research (5 papers), Diabetes and associated disorders (4 papers) and Bone health and treatments (3 papers). Radhika Narla is often cited by papers focused on Bone health and osteoporosis research (5 papers), Diabetes and associated disorders (4 papers) and Bone health and treatments (3 papers). Radhika Narla collaborates with scholars based in United States and South Korea. Radhika Narla's co-authors include Barbara Brooks‐Worrell, Jerry P. Palmer, Han Uk Ryu, Hyun Goo Kang, Edward J. Boyko, Sun Ok Song, Katherine D. Wysham, Joshua F. Baker, Gary S. Stein and Jong‐Sup Bae and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Radhika Narla

17 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radhika Narla United States 10 115 87 70 70 64 19 353
Sung Hee Ihm South Korea 9 122 1.1× 46 0.5× 65 0.9× 115 1.6× 71 1.1× 27 386
Maria E. Ramirez United States 12 100 0.9× 111 1.3× 95 1.4× 172 2.5× 141 2.2× 20 592
Ertuğrul Taşan Türkiye 11 58 0.5× 27 0.3× 52 0.7× 149 2.1× 54 0.8× 31 307
Kerstin Hartmann Germany 6 86 0.7× 23 0.3× 24 0.3× 64 0.9× 41 0.6× 10 316
Madi El-Haj Israel 13 95 0.8× 31 0.4× 159 2.3× 22 0.3× 48 0.8× 22 421
Roshini Sathiaseelan United States 11 173 1.5× 50 0.6× 26 0.4× 30 0.4× 50 0.8× 14 381
Mei‐Leng Cheong Taiwan 13 191 1.7× 39 0.4× 107 1.5× 60 0.9× 52 0.8× 31 518
Leonardo M. Porchia Mexico 10 160 1.4× 36 0.4× 28 0.4× 109 1.6× 55 0.9× 46 411
Jong Yun Hwang South Korea 14 178 1.5× 46 0.5× 61 0.9× 38 0.5× 63 1.0× 44 603
Katarzyna Łącka Poland 11 93 0.8× 96 1.1× 20 0.3× 158 2.3× 30 0.5× 75 401

Countries citing papers authored by Radhika Narla

Since Specialization
Citations

This map shows the geographic impact of Radhika Narla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radhika Narla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radhika Narla more than expected).

Fields of papers citing papers by Radhika Narla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radhika Narla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radhika Narla. The network helps show where Radhika Narla may publish in the future.

Co-authorship network of co-authors of Radhika Narla

This figure shows the co-authorship network connecting the top 25 collaborators of Radhika Narla. A scholar is included among the top collaborators of Radhika Narla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radhika Narla. Radhika Narla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Narla, Radhika, et al.. (2025). Late-onset Complications in a Chronic Proton Pump Inhibitor User: Electrolyte Abnormalities and a Diagnostic Approach. JCEM Case Reports. 3(7). luaf125–luaf125. 1 indexed citations
2.
Narla, Radhika & Robert A. Adler. (2024). Rationale for osteoporosis screening in men. Osteoporosis International. 36(2). 163–166.
3.
Thomas, Melbin, et al.. (2023). SAT219 Severe Isolated Hypocalcemia With Cetuximab & Irinotecan Chemotherapy. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
4.
Vimalananda, Varsha G., Juan P. Brito, Leslie Eiland, et al.. (2022). Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society. The Journal of Clinical Endocrinology & Metabolism. 107(11). 2953–2962. 26 indexed citations
5.
Wysham, Katherine D., Joshua F. Baker, & Radhika Narla. (2022). Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 36(3). 101757–101757. 7 indexed citations
6.
Narla, Radhika, et al.. (2022). Risk factors for osteoporosis and fractures in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 36(3). 101773–101773. 27 indexed citations
7.
Narla, Radhika & Robert A. Adler. (2021). Osteoporosis care amidst the prolonged pandemic. Journal of Endocrinological Investigation. 44(7). 1353–1361. 9 indexed citations
8.
Dinh, Kathryn T. & Radhika Narla. (2021). Single Dose of Denosumab Effective for Management of Bisphosphonate-Refractory Hypercalcemia of Malignancy Related to Non-Small Cell Lung Cancer. Journal of the Endocrine Society. 5(Supplement_1). A223–A223.
9.
Cirrincione, Lauren R. & Radhika Narla. (2020). Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies. The Journal of Applied Laboratory Medicine. 6(1). 219–235. 2 indexed citations
10.
Narla, Radhika, et al.. (2019). Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures. Journal of Investigative Medicine. 67(4). 743–749. 9 indexed citations
11.
Adesina, Oyebimpe, Isaac Jenkins, Qian Wu, et al.. (2019). Urinary cross-linked carboxyterminal telopeptide, a bone resorption marker, decreases after vaso-occlusive crises in adults with sickle cell disease. Blood Cells Molecules and Diseases. 80. 102369–102369. 4 indexed citations
12.
Song, Sun Ok, et al.. (2019). Metabolic Consequences of Obstructive Sleep Apnea Especially Pertaining to Diabetes Mellitus and Insulin Sensitivity. Diabetes & Metabolism Journal. 43(2). 144–144. 62 indexed citations
13.
Narla, Radhika, Takao Hashimoto, Kathleen A. Kelly, & Anthony P. Heaney. (2016). Hypoglycemia: A tale of three causes. SHILAP Revista de lepidopterología. 2. 4–6. 4 indexed citations
14.
Brooks‐Worrell, Barbara, et al.. (2013). Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obesity and Metabolism. 15(s3). 137–140. 31 indexed citations
15.
Brooks‐Worrell, Barbara, Dinakar Iyer, Christiane S. Hampe, et al.. (2013). Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes. Diabetes Care. 36(12). 4098–4103. 29 indexed citations
16.
Brooks‐Worrell, Barbara, Radhika Narla, & Jerry P. Palmer. (2012). Biomarkers and immune-modulating therapies for Type 2 diabetes. Trends in Immunology. 33(11). 546–553. 36 indexed citations
17.
Bae, Jong‐Sup, Soraya Gutiérrez, Radhika Narla, et al.. (2006). Reconstitution of Runx2/Cbfa1‐null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. Journal of Cellular Biochemistry. 100(2). 434–449. 68 indexed citations
18.
Uckun, Fatih M., Chengzhou Mao, He Huang, et al.. (2001). Spongistatins as Tubulin Targeting Agents. Current Pharmaceutical Design. 7(13). 1291–1296. 15 indexed citations
19.
Uckun, Fatih M., E. Sudbeck, Chen Mao, et al.. (2001). Structure-Based Design of Novel Anticancer Agents. Current Cancer Drug Targets. 1(1). 59–71. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung Hee Ihm Breakdown of academic impact, for papers by Maria E. Ramirez Breakdown of academic impact, for papers by Ertuğrul Taşan Breakdown of academic impact, for papers by Kerstin Hartmann Breakdown of academic impact, for papers by Madi El-Haj Breakdown of academic impact, for papers by Roshini Sathiaseelan Breakdown of academic impact, for papers by Mei‐Leng Cheong Breakdown of academic impact, for papers by Leonardo M. Porchia Breakdown of academic impact, for papers by Jong Yun Hwang Breakdown of academic impact, for papers by Katarzyna Łącka
Rankless by CCL
2026